An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs

Active, not recruitingOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Peripheral Arterial Disease (PAD)

Trial Locations (1)

Medical Data Vision Co., Ltd, Tokyo